elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018
Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.
P2860
Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa4869d232825b3b1eee42ea06478ccff0460989
P2860
The Gordian Knot of dysbiosis, obesity and NAFLD.